Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

An international team led by Goethe University Frankfurt has identified an intracellular sensor that monitors the quality of so-called MHC-I molecules, which help the immune system recognize and kill ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

A new immune structure found in liver tumors could improve treatment for liver cancer patients. These structures are linked ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other copy is inactivated by an inherited mutation. This means that a total loss ...

November 11, 2024) There are processes in the human body that can suppress the growth and proliferation of cancer cells.

Novel method identified protein degraders that target Pin1, a protein involved in pancreatic cancer development.

Researchers from the Mattiroli group have found that the way DNA is packaged in cells can directly impact how fast DNA itself ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.